CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells

J Exp Clin Cancer Res. 2022 Jun 2;41(1):188. doi: 10.1186/s13046-022-02381-7.

Abstract

Background: Circular RNAs (circRNAs) are essential participants in the development and progression of various malignant tumors. Previous studies have shown that cell migration-inducing protein (CEMIP) accelerates prostate cancer (PCa) anoikis resistance (AR) by activating autophagy. This study focused on the effect of circCEMIP on PCa metastasis.

Methods: This study gradually revealed the role of circ_0004585 in PCa anoikis resistance via quantitative real-time PCR (qRT-PCR) analysis, western blotting, pull-down assays, and dual fluorescence reporter assays.

Results: Functionally, circ_0004585 promoted PCa cells invasion and metastasis both in vitro and in vivo. Mechanistically, circ_0004585 directly interacted with miR-1248 to upregulate target gene expression. Furthermore, target prediction and dual-luciferase reporter assays identified transmembrane 9 superfamily member 4 (TM9SF4) as a potential miR-1248 target. Pathway analysis revealed that TM9SF4 activated autophagy to promote PCa cells anoikis resistance via mTOR phosphorylation.

Conclusions: These results demonstrated that circ_0004585 played an oncogenic role during PCa invasion and metastasis by targeting the miR-1248/TM9SF4 axis while providing new insight into therapeutic strategy development for metastatic PCa.

Keywords: Anoikis; Autophagy; Prostate cancer; TM9SF4; circ_0004585.

MeSH terms

  • Anoikis / genetics
  • Autophagy / genetics
  • Humans
  • Male
  • Membrane Proteins
  • MicroRNAs* / genetics
  • Prostate
  • Prostatic Neoplasms* / genetics

Substances

  • Membrane Proteins
  • MicroRNAs
  • TM9SF4 protein, human